The first immunohistochemical biomarkers which have laid the foundation for the classification of the BC subtypes mainly include the expression of the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to breast cancer.